Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.

[1]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[2]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[3]  L. Wallentin,et al.  Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram. , 2000, The American journal of cardiology.

[4]  M. Galli.  [Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[5]  J. W. Schaeffer,et al.  ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations , 2000, Circulation.

[6]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[7]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[8]  L. Wallentin.  Low-Molecular-Weight Heparin as a Bridge to Timely Revascularization in Unstable Coronary Artery Disease – an Update of the Fragmin during Instability in Coronary Artery Disease II Trial , 2000, Pathophysiology of Haemostasis and Thrombosis.

[9]  E W Steyerberg,et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. , 2000, Circulation.

[10]  J. Zimmerman,et al.  Diagnostic marker cooperative study for the diagnosis of myocardial infarction. , 1999, Circulation.

[11]  R. Califf,et al.  Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: experience from GUSTO-IIb. Global Utilization of Strategies for Total Occlusion. , 1999, American heart journal.

[12]  R. Califf,et al.  Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia , 1998 .

[13]  J. Saffitz,et al.  Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. , 1997, Clinical chemistry.

[14]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[15]  R Roberts,et al.  Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. , 1990, Circulation.